Congressional Briefing on Lifesaving NIH Infectious Disease Research
TAG was among thirteen organizations that cosponsored this Congressional briefing held on July 9, 2025. Briefing materials and presentations are available for download.
TAG to Honor Founding Member and Activist Dr. Richard Lynn as Third and Final Honoree at 2025 Research in Action Awards
Treatment Action Group (TAG) is proud to announce Dr. Richard Lynn — scientist, activist, philanthropist, and founding member of TAG — as the third and final honoree for the 2025 Research in Action Awards (RIAA), to be held on October 20 at the Angel Orensanz Foundation in New York City.
TAG to Honor Gloria Reuben at 2025 Research in Action Awards
Treatment Action Group (TAG) is proud to announce that Gloria Reuben — award-winning actress, singer, author, and longtime HIV/AIDS advocate — will be honored at the 2025 Research in Action Awards (RIAA) for her unwavering dedication to public health, activism, and the arts.
Tom Postilio & Mickey Conlon Named Event Chairs for TAG’s 2025 Research in Action Awards
Treatment Action Group (TAG) is proud to announce that Tom Postilio and Mickey Conlon — renowned philanthropists, internationally acclaimed real estate leaders, and dedicated advocates for public health — will serve as Event Chairs for the 2025 Research in Action Awards (RIAA).
Hearing on Biomedical Research – Keeping America’s Edge in Innovation
Treatment Action Group (TAG) is issuing an urgent call to protect the integrity of biomedical research and public health.
TAG Joins Call for the Resignation of HHS Secretary RFK, Jr., as a “Danger to the Public’s Health”
Treatment Action Group (TAG) decries the vicious and inchoate attacks on HHS since the advent of the new administration, which have escalated significantly over the past week.
Tuberculosis Research at the National Institutes of Health – Saving Lives, Shrinking Costs, Fueling American Jobs and Innovation
This policy brief describes the crucial role NIH plays in supporting research on new products to prevent, diagnose, and cure TB. This research is especially important at a time when new forms of drug resistance are emerging globally, and rates of TB are rising in the U.S. With continued and increased funding, NIH can protect Americans from the growing threat of TB at home and abroad.
TAG Condemns Plans to Eliminate Vital HIV programs at the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
TAG is deeply concerned about the Trump administration’s potential plans to eliminate vital HIV programs at the CDC’s Division of HIV Prevention (DHP) and other programs in the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).
Treatment Action Group Opposes the Nomination of Dr. Jay Bhattacharya for Director of the U.S. National Institutes of Health
The nomination of Dr. Jay Bhattacharya for Director of the United States National Institutes of Health (NIH) continues the pattern of un- and under-qualified nominees put forward by the current administration.
TAG Executive Director Warns: “They Don’t Care If We Live or Die”
This title of this page is one of the quotes by Mark Harrington from his recent appearance on +Life Media with TAG board member Karl Schmid. We rate this video absolutely must watch!